{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:59:39Z","timestamp":1790056779812,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Novartis Farma S.p.A., Origgio, Italy"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pupt.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:15:00Z","timestamp":1536106500000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study"],"prefix":"10.1016","volume":"53","author":[{"given":"Gino","family":"Scalone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6468-4446","authenticated-orcid":false,"given":"Francesco","family":"Ventrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Bussoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8 Angelo","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dadduzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Schino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-4198","authenticated-orcid":false,"given":"Riccardo","family":"Pela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bartezaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8815-3666","authenticated-orcid":false,"given":"Paolo","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Alberto","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Muscianisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2018.09.001_bib1","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.pupt.2018.09.001_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152618","article-title":"Continuing to confront COPD international patient survey: economic impact of COPD in 12 countries","volume":"11","author":"Foo","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.pupt.2018.09.001_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011898","article-title":"Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol","volume":"6","author":"Morgan","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.pupt.2018.09.001_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1513\/pats.201102-017RM","article-title":"Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation","volume":"8","author":"Soriano","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2018.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.05.020415","article-title":"Global and regional estimates of COPD prevalence: systematic review and meta-analysis","volume":"5","author":"Adeloye","year":"2015","journal-title":"J Glob Health"},{"key":"10.1016\/j.pupt.2018.09.001_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062985","article-title":"The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population","volume":"8","author":"de Marco","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl C","key":"10.1016\/j.pupt.2018.09.001_bib7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0954-6111(03)80024-0","article-title":"The burden of COPD in Italy: results from the Confronting COPD survey","volume":"97","author":"Dal Negro","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.001_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Force, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.001_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","article-title":"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the american college of physicians, american college of chest physicians, american thoracic society, and european respiratory society","volume":"155","author":"Qaseem","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pupt.2018.09.001_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-9-62","article-title":"Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit","volume":"9","author":"Jones","year":"2008","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2018.09.001_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/02770900500448738","article-title":"Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over","volume":"43","author":"Tinkelman","year":"2006","journal-title":"J. Asthma"},{"key":"10.1016\/j.pupt.2018.09.001_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3132\/pcrj.2008.00047","article-title":"Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study","volume":"18","author":"Buffels","year":"2009","journal-title":"Prim. Care Respir. J."},{"key":"10.1016\/j.pupt.2018.09.001_bib13","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.pupt.2018.09.001_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09059180.00002610","article-title":"Impact of exacerbations on COPD","volume":"19","author":"Anzueto","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2018.09.001_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1513\/pats.200512-125SF","article-title":"Pathophysiology of exacerbations of chronic obstructive pulmonary disease","volume":"3","author":"Papi","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2018.09.001_bib16","first-page":"207","article-title":"Frequent exacerbator\" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease","volume":"11","author":"Tomioka","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.09.001_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.rmed.2008.10.017","article-title":"Primary care of the patient with chronic obstructive pulmonary disease in Italy","volume":"103","author":"Cazzola","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.001_bib18","first-page":"15","article-title":"Degree of control of physician-diagnosed asthma and COPD in Italy","volume":"67","author":"Caramori","year":"2007","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.pupt.2018.09.001_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.rmed.2012.03.008","article-title":"How far is real life from COPD therapy guidelines? An Italian observational study","volume":"106","author":"Corrado","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.001_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1742-1241.2007.01447.x","article-title":"Role of primary care in early diagnosis and effective management of COPD","volume":"61","author":"Bellamy","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pupt.2018.09.001_bib21","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD 2011. Available from: www.goldcopd.org. Accessed on December 2017."},{"key":"10.1016\/j.pupt.2018.09.001_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pupt.2018.09.001_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4104\/pcrj.2011.00033","article-title":"Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008","volume":"20","author":"Cazzola","year":"2011","journal-title":"Prim. Care Respir. J."},{"key":"10.1016\/j.pupt.2018.09.001_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1185\/03007995.2014.884492","article-title":"COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners","volume":"30","author":"Maio","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pupt.2018.09.001_bib25","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1080\/03007995.2016.1182900","article-title":"An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014","volume":"32","author":"Visentin","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pupt.2018.09.001_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pupt.2018.02.003","article-title":"Characterization of chronic obstructive pulmonary disease prescribing patterns in the United States","volume":"49","author":"Petite","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2018.09.001_bib27","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1183\/09031936.00126814","article-title":"INSTEAD: a randomised switch trial of indacaterol versus salmeterol\/fluticasone in moderate COPD","volume":"44","author":"Rossi","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.001_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1465-9921-15-77","article-title":"Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)","volume":"15","author":"Rossi","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2018.09.001_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874306401408010093","article-title":"Inhaled corticosteroids and secondary adrenal insufficiency","volume":"8","author":"Sannarangappa","year":"2014","journal-title":"Open Respir. Med. J."},{"key":"10.1016\/j.pupt.2018.09.001_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(12)70052-8","article-title":"Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study","volume":"1","author":"Vogelmeier","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pupt.2018.09.001_bib31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Investigators F: indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2018.09.001_bib32","first-page":"1015","article-title":"LANTERN: a randomized study of QVA149 versus salmeterol\/fluticasone combination in patients with COPD","volume":"10","author":"Zhong","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.09.001_bib33","first-page":"2657","article-title":"Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey","volume":"10","author":"Guclu SZ","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.09.001_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pupt.2016.04.002","article-title":"Bronchodilator treatment for COPD in primary care of four Latin America countries: the multinational, cross-sectional, noninterventional PUMA study","volume":"38","author":"Montes de Oca","year":"2016","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2018.09.001_bib35","first-page":"2207","article-title":"The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK","volume":"10","author":"Brusselle","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T14:30:21Z","timestamp":1566743421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553918301494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"alternative-id":["S1094553918301494"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2018.09.001","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}